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Abstract
Background: Sub-Saharan countries including Nigeria have the highest burden of Human Papillomavirus (HPV)
infection in the world. Most studies on HPV surveillance in Nigeria were done in the southern part of the country.
Geographical and socio-cultural diversity of Nigeria makes these data unlikely to be universally representative for
the entire country. Northern Nigeria especially the North-East carries a higher prevalence of cervical cancer and
many of its risk factors. The region may be harbouring a higher prevalence of HPV infection with a possibility of
different genotypic distribution. This study was carried out to determine the burden and confirm the predominant
HPV genotypes among women presenting for cervical cancer screening at the Federal Teaching Hospital Gombe (FTHG),
North-eastern, Nigeria.
Methods: The study was an observational hospital based cross sectional study among women who presented for
cervical cancer screening in FTHG. A total of 209 consenting women were tested for cervical HPV infection using PCR.
DNA sequencing was carried out on positive samples to determine the prevalent HPV genotypes.
Results: The prevalence of cervical HPV infection among the participants with mean age of 39.6 ± 10.4 years was 48.1 %.
The five most predominant genotypes were 18, 16, 33, 31 and 35, with prevalence of 44.7 %, 13.2 %, 7.9 %, 5.3 % and
5.3 % respectively. Other genotypes observed were 38, 45, 56, 58, 82 and KC5. Multiple HPV infections were detected
among 7.9 % of participants. Risk factors such as level of education (X2 = 15.897; p = 0.007), age at sexual debut
(X2 = 6.916; p = 0.009), parity (X2 = 23.767; p = 0.000), number of life time sexual partners (X2 = 7.805; p = 0.005), age
at first pregnancy (X2 = 10.554; p = 0.005) and history of other malignancies (X2 = 7.325; p = 0.007) were found to
have a statistically significant association with HPV infection.
Conclusion: This study identified a high burden of HPV infection in Northern Nigeria while also confirming HPV
18 and 16 as the most predominant genotypes. It further justifies the potential benefit of the currently available
HPV vaccines in the area. A larger and community based study is however recommended for better representation of
the area.
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Introduction
Among the approximately 200 known HPV types, about
40 can infect the cervix out of which 13 types (16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 66) from among
the alpha species have been classified as group 1 carcin-
ogens [1–3]. Of these oncogenic viruses, HPV-16 and
HPV-18 are the most prevalent worldwide. They have
been associated with about 70 % of invasive cervical can-
cer (ICC) worldwide and about 50 % of cervical intrae-
pithelial neoplasia grade 3 (CIN3) [1, 4]. Aetiologically,
Five HPV types (16, 18, 31, 33, and 45) have been linked
to 80 % of cervical cancers while the other types contrib-
ute the remaining 20 % [5]. The high-risk HPV (hr-HPV)
types are also implicated in vulvar, vaginal, penile, anal,
and oropharyngeal neoplasms [5]. Infection of the genital
tract with HPV is considered the most common sexually
transmitted infection worldwide [5]. Several HPV geno-
types tend to be transmitted together, leading to a high
proportion (20–30 %) of concurrent infections with differ-
ent types [1].
Worldwide the incidence and prevalence of HPV
peaks at younger age soon after the start of sexual activ-
ity below the age of 25–35 years but subsequently
declines with infections clearing as the infected individ-
ual grows older [5, 6]. Globally, age-adjusted prevalence
of HPV in women with normal cytology is estimated
at 10.4 %, ranging from 8.1 % in Europe to 22.1 % in
Africa [5].
Persistent HPV infection of the cervical epithelium is
the major risk factor for cervical cancer as more than
99 % of cases contain hr-HPV. Early/polygamous mar-
riages [7], high parity, tobacco smoking, long-term hor-
monal contraceptive use, co-infection with Chlamydia
trachomatis, herpes simplex virus type 2, HIV, immuno-
suppression, certain dietary deficiencies, genetic and im-
munological host factors have been observed to be
major contributory factors to cervical cancer [8]. Other
risk factors for cervical cancer include imbalanced vagi-
nal flora, having an uncircumcised male partner and low
socio-economic status [5, 9].
Cervical cancer is the second most common cancer
in women worldwide and a leading cause of cancer
deaths in developing countries [7]. The prevalence of
cervical infection with HPV particularly high risk types
that cause cervical cancer varies greatly worldwide
[10].
Despite being among the areas with highest prevalence
in the world, awareness about HPV and its association
with cervical cancer is still poor in Nigeria [11]. The
North-East zone of Nigeria has the highest poverty rates
in the country [12]. Socio-cultural practices in the region
also encourages early marriage and polygamy [13]. Despite
cervical cancer being the commonest genital tract malig-
nancy in this region (70.5 %), only 11.5 % of women ever
had a Pap smear with very poor knowledge of HPV vac-
cine even among healthcare workers [14, 15].
In this study we determined the prevalence of HPV
and its associated risk factors among women presenting
for cervical cancer screening in Gombe, North-eastern
Nigeria.
Materials and methods
Study area and population
The study was carried out among 209 women who pre-
sented for cervical cancer screening between August 2013
and May 2014 at the FTH Gombe. However, the screening
for many of the participants was based on referral follow-
ing risk assessment by healthcare staff. Ethical approval
was obtained from Research and Ethics Committee of
FTH Gombe. Recruited women were counselled and all
those who gave informed consent were enrolled into the
study.
Specimen collection and storage
Rovers® Cervex-Brush® cell sampling device (Rovers
Medical Devices B.V 5347 KV Oss, The Netherlands)
was used for specimen collection. Specimen was ob-
tained by inserting the cytobrush into the cervical canal
and rotating it four times in a clockwise direction to col-
lect all the cervical epithelial cells which adhered to the
flat sides of the bristles.
The brush was then inserted into the vial containing
preservative fluid. Liquid-based cytology system (Liqui-
PREP by LGM International, Inc, Melbourne, FL, USA)
for collection and transport of cervical specimen was
used.
DNA extraction
DNA from exfoliated cervical cells collected in the
preservative fluid (Liqui-PREP) was extracted using pro-
teinase K digestion, followed by phenol-chloroform ex-
traction and ethanol precipitation. Gel extraction prior to
DNA cleaning/purification for sequencing was done using
QIAquick Gel Extraction Kit (QIAGEN Sample & Assay
Technologies, Germany).
Detection and typing of HPV
All the cervical specimens were tested for the pres-
ence of oncogenic HPV DNA using a nested Polymer-
ase Chain Reaction (nPCR) with GP5+/GP6+ (GP5+
[5′ TTTGTTACTGTGGTAGATACTAC-3′] and GP6+
[5′- GAAAAATAAACTGTAAATCATATTC-3′]) [16] and
PGMY 09/11 [17] consensus primers which amplifies a
150 bp fragment of the L1 HPV genomic region. Accu-
Power HotStart Premix (Bioneer Corporation, South
Korea) was used for the PCR. Genotypic identification was
achieved by direct sequencing using the Gp 6+ oligopri-
mer. Thermal cycler (Bio Rad) and Sequencing machine
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(Beckman Coultier CEQ 2000XL) were used for PCR and
sequencing respectively. Sequence alignments were per-
formed against various standard HPV genotype sequences
stored in the GenBank database by on-line BLAST ana-
lysis to arrive at specific genotyping. The procedures were
carried at the DNA Labs, Kaduna, Nigeria.
Data analysis
Descriptive and inferential statistical analysis of the data
was done using Statistical Package for the Social Sciences
version 22 (SPSS Inc., Illinios, USA). Student’s t test was
used to compare means for continuous variables, while
categorical variables were summarized as proportions and
further analyzed using Chi square to assess association be-
tween them. A logistic regression was performed to ascer-
tain the effects of variables which showed a statistically
significant association with HPV testing based on Chi
square. Figures and tables were appropriately used in
representing the analyzed data (Additonal file 1).
Results
Socio-demographic characteristics and HPV infection
Table 1 showed the association between socio-
demographic characteristics of the participants and HPV
infection. A total of two hundred and nine women par-
ticipated in the study with their mean age being
39.6 years and standard deviation (SD) of ±10.4 years.
Majority 127 (61.2 %) were between the ages of 30 and
45 years with only 36 (17.2 %) and 45 (21.5 %) being
below 30 years and above 45 years respectively. The
mean age of women found to be positive for HPV was
40.79 (±11.23) years compared to 38.49 (±9.47) years
among those with no HPV infection. Student t test
showed no statistically significant difference between the
mean ages (P = 0.111).
More than half, 110 (53.4 %) were educated up to ter-
tiary level with only 32 (15.4 %) having no formal educa-
tion while 14 (6.7 %) and 51 (24.5 %) had primary and
secondary education respectively. Nearly all, 182 (88.0 %)
were married as both single and divorced women
accounted for only 3.8 % each while 4.3 % were widows.
Majority, 128 (64.8 %) of the women were from monog-
amous family settings. Less than half, 99 (48.1 %) were
employed (government and private) with all the remaining
108 (51.9 %) being unemployed among which house wives
were predominant. Muslims were slightly more 118
(56.5 %) than Christians 90 (43.5 %).
Except for level of education, other socio-demographic
characteristics did not show any statistically significant
association with HPV infection.
Analysis of HPV infection
HPV DNA was detected in 100 (48.1 %) of the partici-
pants while 108 (51.9 %) were negative for the virus.
Overall, ten different HPV types were identified from
this study. HPV types 18 and 16 were the most predom-
inant with proportions of 44.7 % and 13.2 % respectively.
Multiple HPV infections were identified among 7.9 % of
the specimens. Other genotypes identified were types 31,
33, 35, 38, 45, 56, 58, 82 and KC5 with corresponding
proportions of 5.3 %, 7.9 %, 2.6 %, 2.6 %, 2.6 %, 2.6 %,
2.6 %, 5.3 % and 2.6 % respectively. Of the 209 partici-
pants, normal cytological findings were observed among
126 (61.6 %) while 80 (39.0 %) had abnormal features
and 3 (1.4 %) had unsatisfactory smears for cytologic
studies. Figure 1 shows the percentage distribution of
the different cytological findings in comparison with cor-
responding HPV types.
Risk factors for HPV infection
Table 2 showed the association between HPV infection
and some risk factors within the participants. Of the 67
participants who had early sexual debut (earlier than
18 years of age), 41 (61.2 %) were positive for HPV DNA
as against 57 (41.6 %) of the respondents who started
their sexual life at or later than 18 years of age. Early
sexual debut showed a statistically significant association
with HPV infection (X2 = 6.916, P = 0.009). Multiple life
time sexual partners also conferred a significant risk for
HPV infection (X2 = 7.805, P = 0.005) as 26 (68.4 %) out
of the 38 respondents with multiple sexual partners were
HPV positive compared to 71 (43.3 %) out of 164 with
single life time sexual partner. Statistically significant as-
sociation was also observed between ages at first preg-
nancy (primigravidity) and HPV infection (X2 = 10.554,
P = 0.005) as respondents with history of early pregnancy
(less than 18 years) showed higher percentage of HPV
infection (75.0 %) in comparison to 43.7 % and 42.9 % for
normal and late age of primigravidity respectively. Parity
of the participants also showed a statistically significant
association with HPV infection (X2 = 23.767, P = <0.001)
with grand multiparous and great grand multiparous
women showing a higher percentage of infection; 62.3 %
and 80 % respectively. Although women in a polygamous
family setting showed higher proportion of HPV infection
than those in monogamous setting, the association was
not statistically significant (X2 = 1.517, P = 0.468). Family
history of cervical cancer did not reveal a significant asso-
ciation with HPV infection (X2 = 0.719, P = 0.397) but his-
tory of other malignancies had a statistically significant
association with HPV infection (X2 = 7.325, P = 0.007).
Among those with history of other malignancies, the
type of malignancy (gynaecologic or others) did not
show a statistically significant association with HPV
infection (X2 = 0.522, P = 0.470).
Other factors as participants’ HIV status, partners’
use of condom and use of hormonal contraceptives
did not show statistically significant association with
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HPV infection. Although not shown in any of the ta-
bles, history suggestive of genital tract infection (vagi-
nal discharge, dyspareunia and vaginal bleeding),
history of alcohol consumption and cigarette smoking
did not show statistical significance in associated with
HPV infection. Partners’ circumcision status could not
be analyzed as all respondents had circumcised sexual
partners.
Logistic regression was performed to ascertain the ef-
fects of level of education, age at sexual debut, parity,
number of sexual partners age at primigravidity and his-
tory of other malignancies on the likelihood that partici-
pants have HPV infection (Table 3).
Discussion
This study reveals a 48.1 % prevalence of cervical HPV
infection among women who presented for cervical can-
cer screening in Gombe, north-eastern Nigeria. It is one
of the highest prevalence rates among one of the oldest
studied populations (mean age of 39.6 ± 10.4 years) to be
ever reported from any part of Nigeria and the first from
North-Eastern Nigeria [6, 10, 11, 18–20]. Although there
are only a few studies from Northern Nigeria, a high
prevalence of 76 % reported from Kano further high-
lights the possibility of this region carrying the highest
HPV burden in the country [18].
Several Nigerian studies among diverse population
groups had reported lower prevalence rates including
19.6 % among HIV infected patients in Lagos [19], 26.3 %
in Ibadan [11], 14.7 % in Irun [6] and 25 % in Abuja [21].
This disparity may be explained by variations among the
different study populations with varying exposures to dif-
ferent risk factors based on diverse socio-cultural and geo-
graphical differences. This study was conducted among
women presenting for cervical cancer screening with many
of them being referred by a healthcare worker following
complaints of symptoms suggestive of either genital tract
Table 1 Association between socio-demographic factors and
HPV infection
Presence of HPV DNA Total X2 P value




<30 17 (17.0 %) 19 (17.6 %) 036 0.642 0.725
30–45 59 (59.0 %) 68 (63.0 %) 127
>45 24 (24.0 %) 21 (19.4 %) 045
Total 100 (100 %) 108 (100 %) 208
Type of Family
Monogamous 59 (61.5 %) 69 (67.6 %) 128 0.829 0.363
Polygamous 37 (38.5 %) 33 (32.4 %) 070




15 (15.0 %) 17 (15.9 %) 0 32 15.897 0.007*
Primary 10 (10.0 %) 04 (03.7 %) 014
Secondary 24 (24.0 %) 27 (25.2 %) 051
OND/NCE/HND 40 (40.0 %) 33 (30.8 %) 0 73
University
graduate
05 (05.0 %) 23 (21.5 %) 0 28
Others 06 (06.0 %) 03 (02.8 %) 0 09
Total 100 (100 %) 107 (100 %) 207
Marital Status
Married 88 (88.0 %) 94 (87.9 %) 182 1.963 0.580
Single 03 (03.0 %) 05 (04.7 %) 008
Divorced 03 (03.0 %) 05 (04.7 %) 008
Widow 06 (06.0 %) 03 (02.8 %) 009
Total 100 (100 %) 107 (100 %) 207
Employment Status
Employed 47 (47.0 %) 52 (48.6 %) 099 0.053 0.818
Unemployed 53 (53.0 %) 55 (51.4 %) 108
Total 100 (100 %) 107 (100 %) 207
Religion
Islam 53 (44.9 %) 65 (60.2 %) 118 1.092 0.296
Christianity 47 (52.2 %) 43 (38.8 %) 090




75 (75.0 %) 87 (81.3 %) 162 1.260 0.533
Other LGAs 18 (18.0 %) 15 (14.0 %) 033
Outside Gombe
state
07 (07.0 %) 05 (04.7 %) 012
Total 100 (100 %) 107 (100 %) 207
Tribe
Fulani 28 (28.0 %) 29 (27.1 %) 057 3.345 0.341
Tangale 26 (26.0 %) 18 (16.8 %) 044
Table 1 Association between socio-demographic factors and
HPV infection (Continued)
Hausa 11 (11.0 %) 17 (15.9 %) 028
Others 35 (35.0 %) 43 (40.2 %) 078
Total 100 (100 %) 107 (100 %) 207
Type of housing
Personal house 50 (50.0 %) 63 (58.9 %) 113 6.023 0.197
Rented flats 27 (27.0 %) 32 (29.9 %) 059
Self contained 20 (20.0 %) 10 (09.3 %) 030
Single rooms 02 (02.0 %) 02 (01.9 %) 004
Others 01 (01.0 %) 00 (00.0 %) 001
Total 100 (100 %) 107 (100 %) 207
* = statistically significant (i.e. <0.05), OND (Ordinary National Diploma), HND
(Higher National Diploma), NCE (National Certificate of Education), LGA (Local
Government Area)
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infection or cervical cancer. Hence, they are naturally a
selected “high risk” group for HPV infection. There is
widespread polygamy and early marriage [13], with cervical
cancer being the commonest genital tract malignancy in
this poorest region of the country [12, 14]. Early pregnancy
and high parity are all very common in North-Eastern
Nigeria [22]. These and probably other unreported risk fac-
tors in the locality could be responsible for the high preva-
lence of HPV infection in this “high risk region”.
Studies done in other parts of sub-Saharan Africa
among similar population groups have shown similarly
high prevalence rates when compared to the value in
this study. A prevalence of 66.1 % had been reported
among high risk women in Burkina faso [23] while
49.6 % and 60.7 % were also reported among women in
Kenya and Sudan respectively [24, 25]. In contrast,
some non-African countries showed lower prevalence
even among similar population groups with 5.5 % in
Iran [26], and 23.6 % in China [27]. This has further
buttressed the fact that sub-Saharan Africa, particularly
Nigeria carries one of the highest burden of HPV infec-
tion in the world [7, 11]. The predominance of most
positive risk factors for HPV alongside inadequate
knowledge and awareness about this virus in Africa
could be an explanation for the higher prevalence of
the infection in this continent. Moreover, from evolu-
tionary point of view, there are predictions that the
root of some if not all HPV types could be traced to
Africa [28].
The predominance of HPV types 16 and 18 as observed
in this study follows the global trend and is in conformity
with some Nigerian studies [11, 18]. However, the observed
predominance of HPV 18 as against type 16 in this study is
in concert with a similar study from Kano in Northern
Nigeria [18]. This suggests the possibility of Northern
Nigeria harbouring a higher prevalence of HPV 18 than 16
in contrast to the general global trend. Although very few
studies are available to justify this assertion, geographical
differences associated with HPV type distribution had been
previously reported from other parts of the world [29]. Var-
iations were particularly observed in predominance be-
tween the other HPV types found in this study in
comparison to most other Nigerian studies from southern
part of the country [10, 11, 19]. The predominant HPV
types were also different from those reported in Abuja
(North-central Nigeria) [21]. This may be attributable to
geographical variations in addition to culture and other life
styles or partly because most of the studies restricted their
search to specific HPV types while this study had the ad-
vantage of using DNA sequencing to detect wider variety.
Seven (HPV types 16, 18, 31, 33, 35, 45 & 58) out of
the eight (HPV types 16, 18, 31, 33, 35, 45, 52 and 58)
global most common cervical HPV types among women
were also found in this study [30]. The five HPV types
(16, 18, 31, 33 and 45) responsible for 80 % of cancers
[31] are also about the most predominant in this study
accounting for 13.2 %, 44.7 %, 5.3 %, 7.9 % and 2.6 % for
HPVs 16, 18, 31, 33 and 45 respectively. This may prob-
ably have contributed to the higher prevalence of cer-
vical cancer in Northern Nigeria [14]. HPV- KC5 has
been reported to be present in the normal skin among
some rural dwellers in China [32]. More recently, it was
also found in the respiratory tract suggesting the possi-
bility of its presence in some other parts of the body
Fig. 1 Percentage distribution of different cytological findings in comparison with corresponding HPV types. HPV types 31, 35, 38, 45, 56, 82 and
multiple infections were only present in women with normal cytological findings. HPV 58 and KC5 were only found among women with
inflammatory cytological findings. HPV 16 had 20 % normal, 60 % HPV changes and 20 % HSIL. HPV 18 had 58.8 % normal, 17.6 % HPV changes,
11.8 % inflammatory, 5.9 % malignant and 5.9 % HPV changes with inflammation. HPV 33 had 66.6 % normal and 33.3 % inflammatory
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[33]. HPV-KC5 may not confer a risk for cervical cancer
as it does not belong to alpha HPV species which con-
tain all the types responsible for cervical cancer [3].
Low prevalence of multiple HPV infections as ob-
served in this study compared to studies that used type
specific primers (TS-PCR) in genotyping is not unusual
Table 2 Association between some risk factors and HPV infection
Variable Presence of HPV DNA Total X2 P value
Age at sexual debut Positive Negative
N (%) N (%)
<18 years 41 (61.2 %) 26 (38.8 %) 67 (100 %) 6.916 0.009*
≥18 years 57 (41.6 %) 80 (58.4 %) 137 (100 %)
Lifetime sexual partners
Single 71 (43.3 %) 93 (56.7 %) 164 (100 %) 7.805 0.005*
Multiple 26 (68.4 %) 12 (31.6 %) 38 (100 %)
Age at primigravidity
<18 years 24 (75.0 %) 08 (25.0 %) 32 (100 %) 10.554 0.005*
18–28 years 69 (43.7 %) 89 (56.3 %) 158 (100 %)
>28 years 03 (42.9 %) 04 (57.1 %) 07 (100 %)
Parity
Nulliparous 06 (54.5 %) 05 (45.5 %) 11 (100 %) 23.767 <0.001*
Primiparous 02 (15.4 %) 11 (84.6 %) 13 (100 %)
Multiparous 32 (35.6 %) 58 (64.4 %) 90 (100 %)
Grand multiparous 48 (62.3 %) 29 (37.7 %) 77 (100 %)
Great-grand multiparous 12 (80.0 %) 03 (20.0 %) 15 (100 %)
Presence of co-wives
No other wife 59 (46.1 %) 69 (53.9.7 %) 128 (100 %) 1.517 0.468
One other wife 20 (50.0 %) 20 (50.0 %) 40 (100 %)
≥2 other wives 17 (58.6 %) 12 (41.4 %) 29 (100 %)
Family history of cervical cancer
No 85 (47.0 %) 96 (53.0 %) 181 (100 %) 0.719 0.397
Yes 14 (56.0 %) 11 (44.9 %) 25 (100 %)
History of other malignancies
No 80 (44.7 %) 99 (55.3 %) 53 (100 %) 7.325 0.007*
Yes 19 (73.1 %) 07 (26.9 %) 26 (100 %)
Type of other malignancies
Gynaecological 17 (73.9 %) 06 (26.1 %) 23 (100 %) 0.522 0.470
Others 01 (50.0 %) 01 (50.0 %) 02 (100 %)
HIV Status
Positive 07 (63.6 %) 04 (36.4 %) 11 (100 %) 0.222**
Negative 47 (43.5 %) 61 (56.5 %) 108 (100 %)
Hormonal contraceptives
No 50 (45.0 %) 61 (55.0 %) 111 (100 %) 0.874 0.350
Yes 48 (51.6 %) 45 (48.4 %) 93 (100 %)
Use of condom
No 73 (50.3 %) 72 (49.7 %) 145 (100 %) 1.026 0.311
Yes 26 (42.6 %) 35 (57.4 %) 61 (100 %)
** = Fischer’s exact test
* = statistically significant (i.e. <0.05)
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[18]. Sequencing has however been shown to detect
more genotypes than TS-PCR suggesting the need to com-
bine both methods for maximum yield [34]. This study
utilized nested PCR using PGMY 09/11 and GP5+/GP6+
which has been shown to be sensitive in detecting wider
range of HPV genotypes and also relatively more effective
in detecting multiple infections[35]. However, the inability
of this study to detect low risk HPV genotypes may be
attributable the PGMY 09/11 primer which has low cap-
acity of detecting lr-HPV and the fact they are generally
fewer in cervical specimens and also more common among
males than females [35–37].
Several variables (level of education, age at sexual de-
but, age at first pregnancy, parity, lifetime sexual part-
ners and history of other malignancies) observed in this
study revealed a statistically significant association with
HPV infection. Low socio-economic status, early mar-
riage/coitarche, polygamy and high parity are all well-
established risk factors for HPV infection [7, 38].
Women with lower levels of education were found to
have a higher risk of HPV infection as shown in this
study and another Nigerian study [21]. Higher educa-
tional level among women is generally associated with
increased knowledge/attitude towards HPV and its pre-
ventive measures with minimal risk factors for the infec-
tion[39]. This has also been observed in this study as
many of participants were highly educated up to tertiary
level as against the corresponding 2 % among the gen-
eral female population in the area[12]. Therefore, this
study may not depict the true picture of the general
population. A study among cervical cancer screening
population group in Lagos, Nigeria also reaffirmed the
statistical significance of age at sexual debut, parity and
lifetime sexual partners as risk factors for HPV infection
[20]. In contrast to this study, Adegbesan-Omilabu et al.,
and Rocha-Brischiliari et al. all reported the use of oral
contraceptive pills, HIV infection and cigarette smoking
as significant risk factors for HPV infection [2, 40]. This
Table 3 Logistic regression analysis of some risk factors for HPV infection
Regression Coefficient P-value Odds ratio 95 % CI
Level of education
No formal education (REF) 1.000
Primary 0.818 0.301 2.267 0.481–10.680
Secondary −0.223 0.809 0.800 0.131–4.874
OND/NCE/HND 0.811 0.286 2.250 0.507–9.993
University graduate 2.219 0.010* 9.200 1.698–49.858
Others 0.501 0.502 1.650 0.383–7.109
Age at sexual debut
≥18 years (REF) 1.000
<18 years −0.794 0.009* 0.452 0.249–0.821
Parity
Nulliparous (REF) 1.000
primiparous 1.204 0.174 3.333 0.588–18.891
Multiparous 3.091 0.002* 22.000 3.076–157.341
Grandmultiparous 1.981 0.004* 7.250 1.905–27.598
Great-grand multiparous 0.882 0.199 2.417 0.629–9.290
Sexual partner (s)
Single (REF) 1.000
Multiple 1.043 0.006* 2.838 1.340–6.011
Age at primigravidity
18–28 years (REF) 1.000
<18 years −1.386 0.109 0.250 0.046–1.365
>28 years −0.033 0.966 0.967 0.210–4.466
History of other malignancies
No (REF) 1.000
Yes 0.363 0.398 1.437 0.619–3.336
* = Statistically significant (i.e. <0.05)
REF Reference Category, OND Ordinary National Diploma, HND Higher National Diploma, NCE National Certificate of Education
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may be attributed to the relatively few percentage of
women that responded to questions on smoking history
(0.5 %), use of hormonal contraception (44.5 %) and
HIV infection (5.2 %). Possible variations in the dur-
ation of exposure to these factors among different stud-
ied populations may also be contributory. Women with
longer duration of exposure to oral contraceptives have
been shown to have 2-fold increase in risk of acquiring
HPV infection [41]. In concert with this study, marital
status, presence of co-wives, religion and tribe were all
not statistically significant risk factors for HPV as
highlighted by some Nigerian studies [20]. Also unre-
lated to the risk of HPV infection in this study is the
use of condom as has also been observed in Ibadan by
Thomas et al. [10].
Majority of the studied population fell within the age
group 30 to 45 years, hence are suitable for enrolment
in screening and treatment programmes in preventing
cervical cancer [6]. In addition, up to 166 (79.8 %) of the
participants in this study were above 30 years of age
which shows that majority may be having a persistent
HPV infection (the actual risk for developing cervical
cancer). This finding further reaffirms the suitability of
HPV DNA detection as an important diagnostic tool for
cervical cancer screening in this population [42].
Logistic regression analysis of the identified risk fac-
tors showed that university education, multiple sexual
partners, multiparity and grand multiparity are associ-
ated with a significantly increased likelihood of having
HPV infection among the participants. The apparent
significance of university education as a risk factor
against our earlier observation and the general trend
may not be unconnected with skewed distribution of
the respondents in terms of educational qualification.
These findings further confirm the need for a larger
and community based study to obviate the lopsided dis-
tribution of the participants as majority of them are ed-
ucated and screening is mostly based on referral by
healthcare workers.
Conclusion
HPV Prevalence of 48.1 % was recorded from this study.
Eleven different HPV types were detected with the five
most predominant types (sequentially) being 18, 16, 33,
31 and 35. Other types were 38, 45, 56, 58, 82 and KC5.
Low level of education, early age at sexual debut, high
parity, multiple life time sexual partners, early age at first
pregnancy and positive history of other malignancies
were the significant risk factors associated with cervical
HPV infection in Gombe.
This study has revealed north-eastern Nigeria as hav-
ing one of the highest HPV prevalence in the country
and also a region that will benefit from the currently
available HPV vaccines.
There is need for a universal, well-coordinated, multi-
centred, rural and urban community based study on
HPV in addition to a comprehensive national cervical
cancer screening programme and improved availability/
accessibility of the currently available HPV vaccines in
all parts of Nigeria.
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